首页> 外文期刊>Clinical Orthopaedics and Related Research >What Are the Complications of Allograft Reconstructions for Sarcoma Resection in Children Younger Than 10 Years at Long-term Followup?
【24h】

What Are the Complications of Allograft Reconstructions for Sarcoma Resection in Children Younger Than 10 Years at Long-term Followup?

机译:在长期后续跟踪超过10年的儿童中对肉瘤切除的同种异体转移重建的并发症是什么?

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundPreservation of limb function after resection of malignant bone tumors in skeletally immature children is challenging. Resection of bone sarcomas and reconstruction with an allograft in patients younger than 10 years old is one reconstructive alternative. However, long-term studies analyzing late complications and limb length discrepancy at skeletal maturity are scarce; this information would be important, because growth potential is altered in these patients owing to the loss of one physis during tumor resection.Questions/purposesAt a minimum followup of 10 years after reconstructions in children younger than 10 years of age at the time of reconstruction, we asked what is (1) the limb length discrepancy at skeletal maturity and how was it managed; (2) the risk of amputation; (3) the risk of allograft removal; and (4) the risk of second surgery resulting from complications?MethodsBetween 1994 and 2006, we performed 22 bone allografts after bone sarcoma resections in children younger than 10 years of age. Of those, none were lost to followup before the minimum followup of 10 years was reached, and an additional six had died of disease (of whom three died since our last report on this group of patients), leaving 16 patients whom we studied here. Followup on these patients was at a mean of 13.5 years (range, 10-22 years). During the period in question, no other treatments (such as extendible prostheses, amputations, etc) were used. The mean age at the time of the original surgery was 7 years (range, 2-10 years), and the mean age of the 16 alive patients at last followup was 20 years (range, 15-28 years). This series included 10 boys and six girls with 14 osteosarcomas and two Ewing sarcomas. Ten reconstructions were performed with an intercalary allograft and six with an osteoarticular allograft. The growth plate was uninvolved in three patients, whereas in the remaining 13, the growth plate was included in the resection (seven intercalary and six osteoarticular allografts). Limb length discrepancy at skeletal maturity was measured with full-length standing radiographs, and data were collected by retrospective study of a longitudinally maintained institutional database. The risk of amputation, allograft removal, and secondary surgery resulting from a complication was calculated by a competing-risk analysis method.ResultsWe observed no limb length discrepancy at skeletal maturity in the three patients with intercalary resections in whom we preserved the physes on both sides of the joint (two femurs and one tibia); however, one patient developed malalignment that was treated with corrective osteotomy of the tibia. The remaining 13 patients developed limb length discrepancy as a result of loss of one physis. Seven patients (four femurs, two tibias, and one humerus) developed shortening of 3 cm (mean, 2.4 cm; range, 1-3 cm) and no lengthening was performed. Six patients developed 3 cm of limb discrepancy at skeletal maturity (all distal femoral reconstructions). In four patients this was treated with femoral lengthening, whereas two declined this procedure (each with 6 cm of shortening). In the four patients who had a lengthening procedure, one patient had a final discrepancy of 4 cm, whereas the other three had equal limb lengths at followup. The risk of amputation was 4% (95% confidence interval [CI], 0-15) and none occurred since our previous report. The risk of allograft removal was 15% (95% CI, 1-29) and none occurred since our previous report on this group of patients.
机译:背景技术肢体未成熟儿患者在切除恶性骨肿瘤后的肢体功能是挑战性的。在10岁以下的患者中切除骨肉瘤和重建,同种异体移植者是一个重建的替代品。然而,在骨骼成熟时分析后期并发症和肢体长度差异的长期研究是稀缺的;这些信息将是重要的,因为由于在肿瘤切除过程中失去了一个生物,这些患者在这些患者中改变了增长潜力。Questions / purposeat在重建时年龄小于10岁以下儿童的10年后的最低随访,我们问了什么(1)骨骼成熟时的肢体长度差异,如何管理; (2)截肢的风险; (3)同种异体移植的风险去除; (4)由并发症导致的第二次手术的风险?方法1994年和2006年,我们在超过10岁以下的儿童切除骨肉瘤切除后进行了22骨同种异体移植物。在那些情况下,在达到10年的最低随访之前,没有人失去动力,并且六人死于疾病(自我们上次关于这群患者的报告以来,其中三次死亡),留下了16名我们在这里学习的患者。这些患者的随访时间为13.5岁(范围,10-22岁)。在有问题的期间,没有使用其他治疗(例如可扩展的假体,截肢等)。原始手术时的平均年龄为7年(范围,2-10岁),最后一次随访患者的平均年龄为20年(范围,15-28岁)。该系列包括10名男孩和六个女孩,患有14个骨肉瘤和两个母羊赛。用间隙同种异体移植物和六种具有骨质颗粒同种异体移植物进行十个重建。在三名患者中未植入生长板,而在其余13名患者中,将生长板包含在切除中(七种闰和六个骨质骨移植物)。通过全长站立射线照相测量骨骼成熟度的肢体长度差异,通过回顾性研究的纵向维护的制度数据库来收集数据。通过竞争风险分析方法计算截肢,同种异体移植除去和继发手术的风险。竞争风险分析方法计算。培训期观察到三个患者在两侧保存物理学的三个患者中,骨骼成熟度没有肢体长度差异关节(两个股骨和一个胫骨);然而,一名患者开发出靶向胫骨的矫形骨质切开术治疗的恶性矿物。其余13名患者由于损失一个物理而产生肢体长度差异。 7名患者(四个股骨,两个胫骨和一个肱骨)缩短了3厘米(平均,2.4厘米;范围,1-3厘米),没有进行延长。六名患者发达>骨骼成熟度3厘米的肢体差异(所有远端股骨重建)。在四个患者中,这是用股骨延长处理的,而两种拒绝此程序(每次缩短6厘米)。在具有延长程序的四名患者中,一名患者的最终差异为4厘米,而另外三个患者在随访时具有相同的肢体长度。截肢的风险为4%(95%置信区间[CI],0-15),因为我们之前的报告以来没有发生。自从我们之前关于这组患者的报告以来,同种异体移植除去的风险为15%(95%CI,1-29),没有发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号